5/4/2024 | 11:30 AM – 12:45 PM | Exhibit Hall F1
Late Breaking - Vaccines and Immunotherapy (AM)
Characterization of CISH-knockout NK cells derived from human peripheral blood and evaluated the antitumor effects in allogeneic glioblastoma
(P945)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 945
Abstract ID: 6154
Presenting Author:
Tsutomu Nakazawa, Nara Med. Univ., Grandsoul Res. Inst. for Immunol.
Co-Authors:
Takayuki Morimoto, Nara Med. Univ.; Ryosuke Maeoka, Nara Med. Univ.; Ryosuke Matsuda, Nara Med. Univ.; Fumihiko Nishimura, Nara Med. Univ.; Takahiro Tsujimura, Clin. Grandsoul Nara; Ichiro Nakagawa, Nara Med. Univ.;
View Abstract Details
Longitudinal assessment of humoral immune response against SARS-CoV-2 in solid cancer patients: Implications for vaccination strategies
(P947)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 947
Abstract ID: 6168
Presenting Author:
Ji Eun Oh, Korea Advanced Inst. of Sci.and Technol.
Co-Authors:
Eunjin Lee, Korea Advanced Inst. of Sci.and Technol.; Ki Seong Lee, Korea Advanced Inst. of Sci.and Technol.;
View Abstract Details
Non-canonical STAT1 activation drives APC activation and potentiates tumor clearance.
(P949)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 949
Abstract ID: 6254
Presenting Author:
sunnie M Yoh, Scripps Res.
Co-Authors:
Sara Cuadrado, Icahn Sch. of Med., Mount Sinai; Jeff A Tomalka, Emory Univ. Sch. of Med.; Yuan Pu, Scripps Res.; Yonina Bykov, Icahn Sch. of Med., Mount Sinai; Adolfo Garcia-Sastre, Icahn Sch. of Med., Mount Sinai; Sumit K Chanda, Scripps Res.;
View Abstract Details
IL-15/IL-15RA CYTOKINE THERAPY ENHANCES CONTROL OF VIRAL REBOUND IN SIV-INFECTED MACAQUES
(P951)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 951
Abstract ID: 6283
Presenting Author:
Vijayakumar Velu, Emory Univ. Sch. of Med.
Co-Authors:
Sakthivel Govindaraj, Emory Univ.; Hemalatha Babu, Emory Univ.; Syed Ali, Univ. of Louisiana, Lafayette; Sheikh Abdul Rahman, Emory Univ.; Susan Pereira Ribeiro, Emory Univ.; Jeff Tomalka, Emory Univ.; Ashish Sharma, Emory Univ.; Rafick P Sekaly; Rama Rao Amara, Emory Univ.; Francois Villinger, Univ. of Louisiana, Lafayette; Vijayakumar Velu, Emory Univ.;
View Abstract Details
Developing a CAR-T that targets human Tn-MUC1 in solid cancers
(P953)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 953
Abstract ID: 6490
Presenting Author:
Diana Rose E Ranoa, Univ. of Illinois, Urbana-Champaign
Co-Authors:
Keith Bailey, Alnylam Pharma.; Edward J Roy, Univ. of Illinois, Urbana-Champaign; Paul J. Hergenrother, Univ. of Illinois, Urbana-Champaign; David M. Kranz, Univ. of Illinois, Urbana-Champaign;
View Abstract Details
Affinity and formulation of a phenyl glycolipid for stimulation of invariant natural killer T cells to inhibit tumor growth
(P955)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 955
Abstract ID: 7280
Presenting Author:
Jung-Tung Hung, Chang Gung Mem. Hosp.
Co-Authors:
Shih-Pin Chiou, Chang Gung Mem. Hosp.; Alice L. Yu, Chang Gung Mem. Hosp.;
View Abstract Details
Exploring Pre-Pandemic SARS-CoV-2-Specific B Cell Responses in the West African Population
(P957)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 957
Abstract ID: 7398
Presenting Author:
Pragati Sharma, Scripps Res.
Co-Authors:
Jonathan Hurtado, Scripps Res.; Terrence Messmer, Scripps Res.; Bryan Briney, Scripps Res.;
View Abstract Details
Comparative high-resolution Cryo-Electron Microscopy reveals distinct binding modes and glycan dependencies of glycan-V3-specific HIV-1 broadly neutralizing antibodies
(P959)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 959
Abstract ID: 7478
Presenting Author:
Amirabbas Maghsoudi, NIAID, NIH
Co-Authors:
Evan M Cale, NIAID, NIH; Jiaxuan Cheng, NIAID, NIH; Nicholas C Morano, Columbia Univ.; Lawrence S Shapiro, Columbia Univ.; Peter D Kwong, Columbia Univ.; Tongqing Zhou, NIAID, NIH; Theodore C Pierson, NIAID, NIH; Nicole A Doria-Rose, NIAID, NIH;
View Abstract Details
Co-evolution of HIV-1 CD4 binding site-specific broadly neutralizing antibody lineage VRC13 and autologous virus reveals pressures driving differential lineage breadth and virus escape
(P961)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 961
Abstract ID: 7572
Presenting Author:
Zoe Vrakas, NIAID, NIH, NIH
Co-Authors:
Evan M. Cale, NIAID, VRC, NIH; Chaim A. Schramm, NIAID, VRC, NIH; Rui Kong, NIAID, VRC, NIH; Tongqing Zhou, NIAID, VRC, NIH; Baoshan Zhang, NIAID, VRC, NIH; Adam S. Olia, NIAID, VRC, NIH; Mehin Suleiman, NIAID, VRC, NIH; Amy Ransier, NIAID, VRC, NIH; Nicole A. Doria-Rose, NIAID, VRC, NIH; Mark Connors, NIAID, NIH; Peter D. Kwong, NIAID, VRC, NIH; Daniel C. Douek, NIAID, VRC, NIH; John R. Mascola, NIAID, VRC, NIH; Rebecca M. Lynch, George Washington Univ. Sch. of Med. and Hlth. Sci.;
View Abstract Details
IBT-V02 vaccination elicits protection against recurrent Staphylococcus aureus skin infections
(P963)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 963
Abstract ID: 7624
Presenting Author:
YU WANG, Johns Hopkins Univ. Sch. of Med.
Co-Authors:
Jing Zhang, Johns Hopkins Univ. Sch. of Med.; Meng-Jen Wu, Johns Hopkins Univ. Sch. of Med.; Laine Feller, Johns Hopkins Univ. Sch. of Med.; Rajan Adhikan, IBT Bioservices; Javad Aman, IBT Bioservices; Nathan Archer, Johns Hopkins Univ. Sch. of Med.;
View Abstract Details
B- and T-cell epitopes from Giardia proteins as candidates in the design of a multipeptide-based vaccine against giardiasis.
(P967)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 967
Abstract ID: 7814
Presenting Author:
Thania Garzon, Univ. de Sonora
Co-Authors:
Carlos Velazquez, Univ. de Sonora; Karina Esparza, Univ. de Sonora; Victoria Yescas, Univ. de Sonora; Lucila Rascon, Univ. de Sonora; Aldo Arvizu, Univ. de Sonora;
View Abstract Details
A TLR7-agonist nanoparticle adjuvant modulates germinal center responses and promotes a broad antibody response against heterologous viral strains of influenza and SARS-CoV-2
(P969)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 969
Abstract ID: 7831
Presenting Author:
Qian Yin
Co-Authors:
Wei Luo, Indiana Univ. Sch. of Med.; Bali Pulendran, Stanford Univ. Sch. of Med.; Mark Davis;
View Abstract Details
A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice.
(P971)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 971
Abstract ID: 7849
Presenting Author:
Mushtaq Ahmed, Univ. of Chicago
View Abstract Details
B cell regulation of CD8 T cell phenotype in vaccination and homeostasis
(P973)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 973
Abstract ID: 7940
Presenting Author:
Cammy Manes, Univ. of Colorado Anschutz Med. Campus
Co-Authors:
Miguel Guerrero-Moreno, Univ. of Colorado Anschutz Med. Campus; Andrew Getahun, Univ. of Colorado Anschutz Med. Campus; Ross Kedl, Univ. of Colorado Anschutz Med. Campus; Jared Klarquist, Univ. of Colorado Anschutz Med. Campus;
View Abstract Details
Leveraging lipid nanoparticle mRNA platform for combined adjuvant delivery
(P975)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 975
Abstract ID: 7948
Presenting Author:
Michael Harbell, Univ. of Colorado Anschutz Med. Campus
Co-Authors:
Benjamin Willett, Univ. of Colorado Anschutz Med. Campus; Scott Thompson, Univ. of Colorado Anschutz Med. Campus; Jared Klarquist, Univ. of Colorado Anschutz Med. Campus; Erika Lasda, Univ. of Colorado Anschutz Med. Campus; Jay Hesselberth, Univ. of Colorado Anschutz Med. Campus; Ross Kedl, Univ. of Colorado Anschutz Med. Campus;
View Abstract Details